Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Malaysian (KLSE) Pharma Industry Analysis

UpdatedMay 27, 2025
DataAggregated Company Financials
Companies6
  • 7D-0.3%
  • 3M-1.1%
  • 1Y-12.3%
  • YTDn/a

The Pharma is pretty flat in the last 7 days, but Duopharma Biotech Berhad has stood out, gaining 4.7%. Unfortunately though, the industry is down 12% over the past 12 months. As for the next few years, earnings are expected to grow by 11% per annum.

Industry Valuation and Performance

Has the Malaysian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 28 May 2025RM 4.0bRM 2.8bRM 230.3m15.6x17.3x1.4x
Fri, 25 Apr 2025RM 3.8bRM 2.8bRM 221.0m17x17.3x1.4x
Sun, 23 Mar 2025RM 3.7bRM 2.8bRM 221.0m16.6x17x1.4x
Tue, 18 Feb 2025RM 4.2bRM 2.7bRM 223.9m17.2x18.6x1.5x
Thu, 16 Jan 2025RM 4.1bRM 2.7bRM 223.9m16.3x18.1x1.5x
Sat, 14 Dec 2024RM 4.2bRM 2.7bRM 223.9m16.9x18.9x1.5x
Mon, 11 Nov 2024RM 4.3bRM 2.7bRM 236.6m14.7x18.2x1.6x
Wed, 09 Oct 2024RM 4.4bRM 2.7bRM 230.0m14.5x19.3x1.6x
Fri, 06 Sep 2024RM 4.2bRM 2.7bRM 230.0m14.4x18.4x1.6x
Sun, 04 Aug 2024RM 4.3bRM 2.6bRM 541.3m12.6x8x1.7x
Tue, 02 Jul 2024RM 4.5bRM 2.6bRM 541.3m13.1x8.3x1.7x
Thu, 30 May 2024RM 4.5bRM 2.6bRM 541.4m13.3x8.3x1.7x
Sat, 27 Apr 2024RM 4.8bRM 2.6bRM 559.3m12.5x8.5x1.8x
Mon, 25 Mar 2024RM 4.6bRM 2.6bRM 559.3m12.3x8.2x1.7x
Wed, 21 Feb 2024RM 4.7bRM 2.6bRM 584.9m12.4x8x1.8x
Fri, 19 Jan 2024RM 4.3bRM 2.6bRM 584.9m12x7.3x1.7x
Sun, 17 Dec 2023RM 4.2bRM 2.6bRM 584.9m12.2x7.2x1.6x
Tue, 14 Nov 2023RM 4.2bRM 2.6bRM 597.0m12.1x7.1x1.6x
Thu, 12 Oct 2023RM 4.3bRM 2.6bRM 604.4m12.1x7.1x1.7x
Sat, 09 Sep 2023RM 4.2bRM 2.6bRM 604.4m12.6x7x1.6x
Mon, 07 Aug 2023RM 4.4bRM 2.6bRM 304.7m14x14.5x1.7x
Wed, 05 Jul 2023RM 4.3bRM 2.6bRM 304.7m14.1x14x1.7x
Fri, 02 Jun 2023RM 4.5bRM 2.6bRM 304.7m14.5x14.9x1.8x
Sun, 30 Apr 2023RM 4.7bRM 2.5bRM 289.8m13.3x16.1x1.9x
Tue, 28 Mar 2023RM 4.7bRM 2.5bRM 289.8m13x16.2x1.9x
Thu, 23 Feb 2023RM 4.6bRM 2.5bRM 270.6m13x17.2x1.9x
Sat, 21 Jan 2023RM 4.7bRM 2.4bRM 270.7m13.1x17.2x1.9x
Mon, 19 Dec 2022RM 4.6bRM 2.4bRM 270.7m13.3x17.1x1.9x
Wed, 16 Nov 2022RM 4.2bRM 2.4bRM 248.4m12.6x17x1.8x
Fri, 14 Oct 2022RM 3.9bRM 2.4bRM 249.0m11.3x15.5x1.6x
Sun, 11 Sep 2022RM 3.9bRM 2.4bRM 249.0m11.9x15.8x1.6x
Tue, 09 Aug 2022RM 3.9bRM 2.3bRM 226.0m13.9x17.1x1.7x
Thu, 07 Jul 2022RM 3.5bRM 2.3bRM 226.0m13.6x15.6x1.5x
Sat, 04 Jun 2022RM 3.8bRM 2.3bRM 226.0m14.4x17x1.7x
Price to Earnings Ratio

17x


Total Market Cap: RM 3.8bTotal Earnings: RM 226.0mTotal Revenue: RM 2.3bTotal Market Cap vs Earnings and Revenue0%0%0%
Malaysian Pharma Industry Price to Earnings3Y Average 13.8x202320242025
Current Industry PE
  • Investors are optimistic on the Malaysian Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 17.3x which is higher than its 3-year average PE of 13.8x.
  • The 3-year average PS ratio of 1.7x is higher than the industry's current PS ratio of 1.4x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 6.8% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Comparison

How does Malaysian Pharma compare with similar industries?

MY Market-1.18%
Healthcare-1.34%
Pharma-0.28%
Pharma-0.28%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
DPHARMA Duopharma Biotech BerhadRM 1.373.0%
+RM 38.5m		8.7%PE18.1x
PLABS PeterLabs Holdings BerhadRM 0.3920.0%
+RM 17.9m		85.7%PE37.8x
RHONEMA Rhone Ma Holdings BerhadRM 0.640.8%
+RM 1.1m		-3.1%PE11.3x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

AHEALTH

RM 2.12

Apex Healthcare Berhad

7D

-1.4%

1Y

-24.3%

KOTRA

RM 4.24

Kotra Industries Berhad

7D

-0.2%

1Y

-5.1%

DPHARMA

RM 1.37

Duopharma Biotech Berhad

7D

3.0%

1Y

8.7%

PLABS

RM 0.39

PeterLabs Holdings Berhad

7D

20.0%

1Y

85.7%

PeterLabs Holdings Berhad's (KLSE:PLABS) 53% Share Price Surge Not Quite Adding Up

May 16
PeterLabs Holdings Berhad's (KLSE:PLABS) 53% Share Price Surge Not Quite Adding Up

YSPSAH

RM 2.23

Y.S.P. Southeast Asia Holding Berhad

7D

-3.9%

1Y

-25.2%

RHONEMA

RM 0.64

Rhone Ma Holdings Berhad

7D

0.8%

1Y

-3.1%